Status:
WITHDRAWN
A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma
Lead Sponsor:
Bernstein Clinical Research Center
Conditions:
Allergy Induced Asthma
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Management of animal induced occupational asthma is mainly avoidance, but this is not feasible for many occupations. Treatment with avoidance and conventional treatment is also not always successful. ...
Eligibility Criteria
Inclusion
- ages 18-65
- occupation that involves close contact with animals
- stable dose of ICS for 30 days
- Skin test positive to one or more animals
- evidence of asthma on spirometry
- demonstrate PEFR variability-
Exclusion
- on allergen immunotherapy
- on prohibited medications
- unstable asthma
- recent URI
- known hypersensitivity to omalizumab-
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00242359
Start Date
November 1 2005
End Date
January 1 2009
Last Update
July 10 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.